| Detected | Trial | Change |
|---|---|---|
| 2026-05-16 | NCT07432386 Methotrexate Versus Apremilast for Pruritus in Psoriasis |
date change Primary completion pushed: 2026-07-20 -> 2026-10-14 |
| 2026-05-16 | NCT07432386 Methotrexate Versus Apremilast for Pruritus in Psoriasis |
date change Completion pushed: 2026-07-20 -> 2026-10-14 |
| 2026-05-15 | NCT07029529 Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder |
Recruitment opened |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07432386 | Methotrexate Versus Apremilast for Pruritus in Psoriasis | Psoriasis | Not Yet Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT04227314 | Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast… | Recurrent Aphtous Stomatitis | Recruiting |
| NCT04804553 | Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis | Active Juvenile Psoriatic Arthritis | Recruiting |
| Phase 2 | |||
| NCT07325266 | Human Laboratory Study of Apremilast for Alcohol Use Disorder | Alcohol Use Disorder | Recruiting |
| NCT07029529 | Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder | Alcohol Use Disorder | Recruiting |
| NCT04488081 | I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients | COVID-19 | Active, Not Recruiting |
| Phase 1 | |||
| NCT05703685 | [18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET | Depression | Recruiting |
| NCT06324435 | Apremilast for Alcohol Use Disorder Treatment in Women and Men | Alcohol Use Disorder | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT07337434 | To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to… | Chronic Plaque Psoriasis | Recruiting |
| Not specified | |||
| NCT07398651 | Apremilast and Adalimumab in Psoriatic Arthritis Patients | Psoriatic Arthritis | Not Yet Recruiting |